Sex hormone levels are not associated with progression of renal disease in male patients with T2DM - 31/03/17

Doi : 10.1016/j.diabet.2016.05.012

E. Feigerlová ^a,^b,^c,^⁎ , P.-J. Saulnier ^c, P. Gourdy ^d,^e,^f, R. Roussel ^g,^h,ⁱ, J.-M. Halimi ^j,^k, E. Gand ^a, D. Dardari ^l, B. Guerci ^m, P. Sosner ^n,^o, M. Marre ^g,^h,ⁱ, P. Zaoui ^p,^q, S. Ragot ^c, S. Hadjadj ^a,^b,^c
for the DIAB 2 NEPHROGENE, SURDIAGENE Study Groups
^a CHU de Poitiers, Service d’Endocrinologie, Pole DUNE, 86021 Poitiers, France
^b Université de Poitiers, UFR Médecine Pharmacie, 86021 Poitiers, France
^c Inserm, CIC 1402 & U1082, 86021 Poitiers, France
^d CHU de Toulouse, Service de Diabétologie, Maladies Métaboliques et Nutrition, 31059 Toulouse, France
^e Inserm, UMR1048/I2MC, 31059 Toulouse, France
^f Université Paul-Sabatier, UMR1048/I2MC, 31059 Toulouse, France
^g Université Paris Diderot, Sorbonne Paris Cité, 75013 Paris, France
^h Inserm, UMRS1138, Centre de Recherche des Cordeliers, 75006 Paris, France
ⁱ AP–HP, Hôpital Bichat, Diabétologie, Endocrinologie Nutrition, DHU FIRE, 75018 Paris, France
^j CHU de Tours, Service Néphrologie, Dialyse et Transplantation, 37000 Tours, France
^k Inserm, Centre d’Investigation Clinique 0202, 37000 Tours, France
^l Hospital of Sud Francilien, Endocrinology Department, 91100 Corbeil-Essonnes, France
^m CHU de Nancy, Service d’Endocrinologie, 54511 Vandoeuvre-lès-Nancy, France
ⁿ Complexe médico-sportif Mon-Stade, 75013 Paris, France
^o Université de Poitiers, Laboratoire MOVE (EA 6314), 86021 Poitiers, France
^p CHU de Grenoble, Service Néphrologie, Dialyse et Transplantation, 38700 Grenoble, France
^q Université Joseph-Fournier, Faculté de Médecine, 38700 Grenoble, France

^⁎Corresponding author at: CHU de Poitiers, Service d’Endocrinologie, Pole DUNE, 86021 Poitiers, France.

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Greater renal function decline (RFD) in type 2 diabetes (T2DM) has been suggested in men compared with women, and imbalances in estrogen/androgen levels have been associated with cardiovascular disease mortality in elderly men, but it remains unclear whether sex hormone disequilibrium is related to diabetic nephropathy (DN) in men with T2DM.

Objective

This study examined the relationship between sex steroid concentrations and renal outcomes in male T2DM patients.

Population and methods

Total testosterone (T), total estradiol (E2), sex hormone-binding globulin (SHBG), and total and calculated free (cf) E2/T ratios were compared in 735 male T2DM patients with (n=513) and without (n=222) DN, using a cross-sectional approach. Also, in a pilot complementary prospective nested case-control cohort, total E2/total T and cfE2/cfT were evaluated according to a hard renal outcome (HRO): end-stage renal disease/doubling of baseline serum creatinine (36 HRO cases, 72 HRO controls) and rate of eGFR decline (68 rapid vs 68 slow RFD).

Result

With the cross-sectional approach, E2 and cfE2 were higher in DN cases vs DN controls (95.5 vs 86.8pmol/L [P=0.0246] and 2.59 vs 2.36pmol/L [P=0.005], respectively). The difference in E2 persisted on multivariate analysis. In the prospective approach, E2 and T concentrations, and total E2/total T and cfE2/cfT2 ratios did not differ in HRO cases vs controls or in patients with rapid vs slow RFD.

Conclusion

Although positively related to DN in the cross-sectional analysis, progression of renal disease in male patients with T2DM was not related to either sex hormone levels or aromatase index as reflected by E2/T ratio.

Le texte complet de cet article est disponible en PDF.

Keywords : Aromatase index, Diabetic nephropathy, Estradiol, Testosterone, Type 2 diabetes

Abbreviations : cfE2, cfT, E2, ERα, eGFR, ESRD, HRO, RRFD, SHBG, SRFD, T, UAC, uACR, UAE

Plan

Introduction

Material and methods

Patients

Laboratory measurements

Statistical methods

Results

Sex steroids and nephropathy: cross-sectional approach

Sex steroids and renal outcomes: nested case-control approaches

Discussion

Authors contributions

Biological sample management

Clinical data

Financial support

Disclosure of interest

Export

Vol 43 - N° 2

P. 140-145 - avril 2017 Retour au numéro

Article précédent

Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome
S. Lindberg, J.S. Jensen, M. Bjerre, J. Frystyk, A. Flyvbjerg, J. Jeppesen, R. Mogelvang

| Article suivant

Increased serum ferritin levels are independently related to incidence of prediabetes in adult populations
G. Meng, H. Yang, X. Bao, Q. Zhang, L. Liu, H. Wu, H. Du, Y. Xia, H. Shi, X. Guo, X. Liu, C. Li, Q. Su, Y. Gu, L. Fang, F. Yu, S. Sun, X. Wang, M. Zhou, Q. Jia, Q. Guo, K. Song, G. Huang, G. Wang, Y. Wu, K. Niu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

connectez-vous ou créez un compte

Sex hormone levels are not associated with progression of renal disease in male patients with T2DM - 31/03/17

Abstract

Background

Objective

Population and methods

Result

Conclusion

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL